395823000: Peginterferon alfa-2b (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)
\Substance categorized by disposition\Immunomodulator\Mediator of immune response and inflammation (substance)\Mediator of immune response\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)
\Substance categorized by disposition\Immunomodulator\Immune enhancement agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)

\Biological substance\Protein and/or protein derivative\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)
\Biological substance\Immunologic substance\Mediator of immune response and inflammation (substance)\Mediator of immune response\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)
\Biological substance\Polypeptide\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Peginterferon alfa-2b (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Peginterferon alfa-2b (substance)	Is a	Interferon alfa-2b	false	Inferred relationship	Some
Peginterferon alfa-2b (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Peginterferon alfa-2b (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiviral (disposition)	true	Inferred relationship	Some
Peginterferon alfa-2b (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Interferon alfa-2b	true	Inferred relationship	Some
Peginterferon alfa-2b (substance)	Is a	Interferon alfa (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing peginterferon alfa-2b (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
PEG-intron redipen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
PEG-intron redipen 150micrograms powder+sterile water 0.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
PEG-intron redipen 120micrograms powder+sterile water 0.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
PEG-intron redipen 50micrograms powder+sterile water 0.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
PEG-intron redipen 80micrograms powder+sterile water 0.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Product containing peginterferon alfa-2b in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Peginterferon alfa-2b only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Peginterferon alfa-2b only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Peginterferon alfa-2b (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469763016	Peginterferon alfa-2b (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1489464015	Peginterferon alfa-2b	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
365881000195114	peginterferone alfa-2b	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
831671000172113	peginterféron alpha-2b	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
980701000241110	péginterféron alfa-2b	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
3341591001000119	Peginterferon alfa-2b	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module